Related Experiment Videos

Arterial oxygen saturation in children receiving rectal midazolam as premedication for oral surgical procedures

J A Roelofse1, J J de V Joubert

  • 1Faculty of Dentistry, University of Stellenbosch, Cape Town, Republic of South Africa.

Anesthesia Progress
|November 1, 1990
PubMed

Insights

Rectal midazolam premedication in children undergoing dental procedures did not affect vital signs. However, higher doses (0.35 and 0.45 mg/kg) significantly improved oxygen saturation levels compared to placebo.

Area of Science:

  • Pediatric Anesthesiology
  • Pharmacology
  • Dental Sedation

Background:

  • Midazolam is commonly used for procedural sedation in pediatric dentistry.
  • Understanding its impact on cardiorespiratory parameters is crucial for patient safety.
  • Optimal dosing for maintaining adequate oxygenation requires further investigation.

Purpose of the Study:

  • To evaluate the effect of different doses of rectal midazolam on arterial oxygen saturation in children.
  • To assess the impact of midazolam premedication on vital signs including blood pressure, respiration, and pulse rate.
  • To compare the efficacy of varying midazolam dosages against a placebo.

Main Methods:

  • Eighty healthy children (2-7 years) undergoing dental procedures were enrolled.
  • A double-blind, randomized controlled trial design was employed.
  • Participants received rectal midazolam (0.25, 0.35, or 0.45 mg/kg) or placebo 30 minutes prior to anesthesia induction.

Main Results:

  • No statistically significant differences were observed in systolic/diastolic blood pressure, respiration, or pulse rates across groups.
  • Oxygen saturation levels in children receiving 0.35 mg/kg (Group B) and 0.45 mg/kg (Group C) midazolam showed significant improvement.
  • These improvements in oxygen saturation were significantly different compared to the placebo group (P = 0.0259).

Conclusions:

  • Rectal midazolam at 0.35 and 0.45 mg/kg effectively maintains or improves arterial oxygen saturation in pediatric dental patients.
  • Midazolam premedication did not adversely affect other vital signs such as blood pressure or respiratory rate.
  • These findings support the use of specific midazolam dosages for optimizing respiratory support during dental procedures.

Related Concept Videos